Institution · Vaccine Research Center
Most cited papers from Vaccine Research Center
What are the most cited papers from Vaccine Research Center?
The most cited paper from Vaccine Research Center is "Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation" (Daniel Wrapp, Nianshuang Wang, Kizzmekia S. Corbett et al., 2020), with 9,833 citations. Next come "Microbial translocation is a cause of systemic immune activation in chronic HIV infection" (3,596) and "An mRNA Vaccine against SARS-CoV-2 — Preliminary Report" (3,519).
Showing 50 of 59 papers. Every paper with more than 687 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Daniel Wrapp, Nianshuang Wang, Kizzmekia S. Corbett et al. · Science | 19 Feb 2020 | 9,833 |
| 2 | Microbial translocation is a cause of systemic immune activation in chronic HIV infection Jason M. Brenchley, David Anthony Price, Timothy W. Schacker et al. · Nature Medicine | 19 Nov 2006 | 3,596 |
| 3 | An mRNA Vaccine against SARS-CoV-2 — Preliminary Report Lisa A. Jackson et al. · New England Journal of Medicine | 14 Jul 2020 | 3,519 |
| 4 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Daniel J. Klionsky et al. · Autophagy | 2 Jan 2021 | 2,743 |
| 5 | Antibody neutralization and escape by HIV-1 Xiping Wei, Julie M. Decker, Shuyi Wang et al. · Nature | 19 Mar 2003 | 2,480 |
| 6 | A human memory T cell subset with stem cell–like properties Luca Gattinoni, Enrico Lugli, Yun Ji et al. · Nature Medicine | 18 Sep 2011 | 2,012 |
| 7 | Vaccine Adjuvants: Putting Innate Immunity to Work Robert L. Coffman, Alan Sher, Robert A. Seder · Immunity | Oct 2010 | 1,961 |
| 8 | Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial Barton F. Haynes et al. · New England Journal of Medicine | 4 Apr 2012 | 1,851 |
| 9 | HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells Michael R. Betts · Blood | 7 Feb 2006 | 1,843 |
| 10 | CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract Jason M. Brenchley, Timothy W. Schacker, Laura E. Ruff et al. · The Journal of Experimental Medicine | 13 Sep 2004 | 1,843 |
| 11 | Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 Xueling Wu et al. · Science | 8 Jul 2010 | 1,817 |
| 12 | HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation Nicolas Chomont, Mohamed El‐Far, Petronela Ancuța et al. · Nature Medicine | 21 Jun 2009 | 1,769 |
| 13 | SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness Kizzmekia S. Corbett et al. · Nature | 5 Aug 2020 | 1,695 |
| 14 | Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike Lihong Liu et al. · Nature | 22 Jul 2020 | 1,622 |
| 15 | Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation Michael R. Betts, Jason M. Brenchley, David Anthony Price et al. · Journal of Immunological Methods | 12 Sep 2003 | 1,600 |
| 16 | T-cell quality in memory and protection: implications for vaccine design Robert A. Seder, Patricia A. Darrah, Mario Roederer · Nature reviews. Immunology | 7 Mar 2008 | 1,589 |
| 17 | Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major Patricia A. Darrah, Dipti T. Patel, Paula Mello De Luca et al. · Nature Medicine | 10 Jun 2007 | 1,415 |
| 18 | Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection Joseph J. Mattapallil, Daniel C. Douek, Brenna J. Hill et al. · Nature | 27 Mar 2005 | 1,289 |
| 19 | HIV preferentially infects HIV-specific CD4+ T cells Daniel C. Douek, Jason M. Brenchley, Michael R. Betts et al. · Nature | May 2002 | 1,278 |
| 20 | Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen Jesper Pallesen, Nianshuang Wang, Kizzmekia S. Corbett et al. · Proceedings of the National Academy of Sciences | 14 Aug 2017 | 1,241 |
| 21 | Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial Peter B. Gilbert et al. · Science | 6 Jan 2022 | 1,218 |
| 22 | Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 Tongqing Zhou, Ivelin S. Georgiev, Xueling Wu et al. · Science | 8 Jul 2010 | 1,187 |
| 23 | Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus Jason S. McLellan et al. · Science | 31 Oct 2013 | 1,172 |
| 24 | Antiretroviral-Drug Resistance among Patients Recently Infected with HIV Susan J. Little, Sarah Holte, Jean‐Pierre Routy et al. · New England Journal of Medicine | 8 Aug 2002 | 1,148 |
| 25 | Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies Ming Li, Feng Gao, John R. Mascola et al. · Journal of Virology | 28 Jul 2005 | 1,096 |
| 26 | Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells Jason M. Brenchley, Nitin J. Karandikar, Michael R. Betts et al. · Blood | 17 Mar 2003 | 1,079 |
| 27 | Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus Hua‐Xin Liao et al. · Nature | 2 Apr 2013 | 1,066 |
| 28 | Seventeen-colour flow cytometry: unravelling the immune system Stephen P. Perfetto, Pratip K. Chattopadhyay, Mario Roederer · Nature reviews. Immunology | 30 Jul 2004 | 1,036 |
| 29 | SARS-CoV-2 infection and persistence in the human body and brain at autopsy Sydney R. Stein et al. · Nature | 14 Dec 2022 | 928 |
| 30 | Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies Masaru Kanekiyo, Chih‐Jen Wei, Hadi Mohamad Yassine et al. · Nature | 21 May 2013 | 923 |
| 31 | HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites Peter D. Kwong et al. · Nature | Dec 2002 | 907 |
| 32 | Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination Norbert Pardi et al. · Nature | 2 Feb 2017 | 903 |
| 33 | Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo Anne W. Rimoin, Prime M. Mulembakani, Sara C. Johnston et al. · Proceedings of the National Academy of Sciences | 30 Aug 2010 | 903 |
| 34 | Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody Jason S. McLellan, Man Chen, Sherman S. Leung et al. · Science | 26 Apr 2013 | 903 |
| 35 | Similarities and differences in CD4+ and CD8+ effector and memory T cell generation Robert A. Seder, Rafi Ahmed · Nature Immunology | 26 Aug 2003 | 900 |
| 36 | Systemic Effects of Inflammation on Health during Chronic HIV Infection Steven G. Deeks, Russell P. Tracy, Daniel C. Douek · Immunity | Oct 2013 | 897 |
| 37 | PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection Constantinos Petrovas, Joseph Paul Casazza, Jason M. Brenchley et al. · The Journal of Experimental Medicine | 5 Sep 2006 | 887 |
| 38 | Animal models for COVID-19 César Muñoz‐Fontela et al. · Nature | 23 Sep 2020 | 884 |
| 39 | SPICE: Exploration and analysis of post‐cytometric complex multivariate datasets Mario Roederer, Joshua L. Nozzi, Martha Nason · Cytometry Part A | 7 Jan 2011 | 871 |
| 40 | Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 Jason S. McLellan et al. · Nature | 22 Nov 2011 | 859 |
| 41 | Broad and potent neutralization of HIV-1 by a gp41-specific human antibody Jinghe Huang, Gilad Ofek, Leo Laub et al. · Nature | 18 Sep 2012 | 859 |
| 42 | Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection Kartik Chandran, Nancy J. Sullivan, Ute Felbor et al. · Science | 14 Apr 2005 | 846 |
| 43 | The who's who of T ‐cell differentiation: Human memory T ‐cell subsets Yolanda D. Mahnke, Tess Melinda Brodie, Federica Sallusto et al. · European Journal of Immunology | 30 Oct 2013 | 839 |
| 44 | Rapid COVID-19 vaccine development Barney S. Graham · Science | 8 May 2020 | 836 |
| 45 | Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing Xueling Wu et al. · Science | 12 Aug 2011 | 825 |
| 46 | Structure and immune recognition of trimeric pre-fusion HIV-1 Env Marie Pancera et al. · Nature | Oct 2014 | 794 |
| 47 | Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine Robert A. Seder et al. · Science | 9 Aug 2013 | 785 |
| 48 | Distribution and three-dimensional structure of AIDS virus envelope spikes Ping Zhu, Jun Liu, Julian W. Bess et al. · Nature | 24 May 2006 | 776 |
| 49 | Structural definition of a conserved neutralization epitope on HIV-1 gp120 Tongqing Zhou, Ling Xu, Barna Dey et al. · Nature | 14 Feb 2007 | 775 |
| 50 | HIV vaccine design and the neutralizing antibody problem Dennis R. Burton, Ronald C. Desrosiers, Robert W. Doms et al. · Nature Immunology | 25 Feb 2004 | 769 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.